Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2000

View Archived Issues

New agents for GI disorders patented by Byk Gulden

Inhibitors of PTP1B in early development at Merck

Proapoptotic and antiproliferative chroman-based compounds designed by RDF

Genentech makes progress on all fronts during first quarter

Polypeptides and their use for treating or diagnosing bacterial infections described by SB

Dual NOS inhibitors/antioxidants designed at SCRAS

Potential antiparkinsonian agents from Kyowa Hakko acting as adenosine A2A antagonists

CPI-1189 may provide neuroprotection via blockade of p38 MAPK phosphorylation

Japanese scientists synthesize new series of MMP inhibitors

Important European market introduction for RenaGel

Sankyo acquires expanded marketing rights to new antihyperlipidemic agent

Worldwide licensing agreement announced for MKC-733

Three products advance in Yamanouchi's clinical pipeline

Y-27632 demonstrates beneficial effects on hepatic fat-storing cells and hepatic fibrosis

Cortex and Shire enter agreement on CX-516 for treatment of ADHD

Genelabs discovers novel RNA-binding compounds

Cambridge Drug Discovery and Teijin to collaborate on novel lead compound development

Results of LeukArrest and Pafase clinical trials

EMEA issues warning and modified labeling for Viramune

Campath MAA accepted for review by European authorities

Discovery Therapeutics initiates phase II atrial fibrillation trial

Abbott and Chrysalis BioTechnology collaborate on Chrysalin development

Another mechanism of action of bacterial cell killing proposed for ramoplanin

Preliminary clinical data confirm positive effect of oral heparin dosage form

Bristol-Myers Squibb resubmits UFT NDA to FDA

New hope for patients suffering from Sjogren's syndrome: FDA approves cevimeline

Orion acquires worldwide rights to Nestorone as hormone replacement therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...